Inventor · disambiguated record
Travis Remarchuk
Also filed as: REMARCHUK TRAVIS · REMARCHUK TRAVIS P · REMARCHUK TRAVIS PAUL
24 granted patents·5 pending applications·109 citations·filing 1996–2025
95Inventor score
Files withAGOURON PHARMA9DENALI THERAPEUTICS INC9ARRAY BIOPHARMA INC5GENENTECH INC4AGOURON PHRAMACEUTICALS INC1
Top patents by PatentIndex Score
29 records- 0192US9278917B2Process for making amino acid compoundsGENENTECH INC·Filed 2013·Granted Mar 8, 2016·7 cites·21 claims
- 0291US10370361B2Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of productionDENALI THERAPEUTICS INC·Filed 2018·Granted Aug 6, 2019·3 cites·27 claims
- 0391US9676730B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 13, 2017·9 cites·15 claims
- 0491US9315471B2Process of making hydroxylated cyclopentapyrimidine compounds and salts thereofGENENTECH INC·Filed 2013·Granted Apr 19, 2016·12 cites·16 claims
- 0590US9790190B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 17, 2017·7 cites·23 claims
- 0690US9309204B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Apr 12, 2016·7 cites·16 claims
- 0789US9416110B2Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 16, 2016·10 cites·4 claims
- 0880US11236100B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·30 claims
- 0980US5705647AIntermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 1996·Granted Jan 6, 1998·24 cites·4 claims
- 1079US11834438B2Process for the preparation of pyrimidinyl-4-aminopyrazole compoundsDENALI THERAPEUTICS INC·Filed 2018·Granted Dec 5, 2023·1 cites·6 claims
- 1178US10851088B2Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of productionDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 1, 2020·1 cites·25 claims
- 1278US9481690B2Polymorphs of 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4,triazol-5-yl)-5,6-dihydrobenzo[f] imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereofGENENTECH INC·Filed 2016·Granted Nov 1, 2016·3 cites·4 claims
- 1375US11851440B2Modulators of eukaryotic initiation factor 2B, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·0 cites·18 claims
- 1474US12497387B2Process for the preparation of pyrimidinyl-4-aminopyrazole compoundsDENALI THERAPEUTICS INC·Filed 2023·Granted Dec 16, 2025·0 cites·5 claims
- 1574US11427571B2Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of productionDENALI THERAPEUTICS INC·Filed 2020·Granted Aug 30, 2022·0 cites·2 claims
- 1672US6355807B1Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediatesAGOURON PHARMA·Filed 2000·Granted Mar 12, 2002·7 cites·25 claims
- 1765US2025388595A1Modulators of eukaryotic initiation factor 2b, compositions and methodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1865US2025376459A1Crystalline forms of a tyk2 inhibitor and uses thereofALUMIS INC·Filed 2023·Application pending·0 cites
- 1964US5925759AMethods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 1997·Granted Jul 20, 1999·6 cites·12 claims
- 2063US9303043B2Process for making benzoxazepin compoundsGENENTECH INC·Filed 2014·Granted Apr 5, 2016·1 cites·10 claims
- 2163US6316625B1Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2000·Granted Nov 13, 2001·1 cites·18 claims
- 2258US2018258054A1Process for making hydroxylated cyclopentylpyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 2357US6117999AMethods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHRAMACEUTICALS INC·Filed 1999·Granted Sep 12, 2000·5 cites·4 claims
- 2452US2022249479A1Modified release formulation of a pyrimidinylamino-pyrazole compound, and methods of treatmentDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2551US6465661B1Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2002·Granted Oct 15, 2002·0 cites·4 claims
- 2651US6084107AIntermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 1997·Granted Jul 4, 2000·4 cites·5 claims
- 2749US6392067B1Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitorsAGOURON PHARMA·Filed 2001·Granted May 21, 2002·0 cites·7 claims
- 2842US6774243B2Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediatesAGOURON PHARMA·Filed 2001·Granted Aug 10, 2004·0 cites·11 claims
- 2939US2003064429A1Efficient methods for the preparation of rhinovirus protease inhibitors, key intermediates and a continuous membrane reactor useful for preparing the sameAGOURON PHARMA·Filed 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →